Apyx Medical vs Iridex
Apyx Medical and Iridex are similar in size: $52.8m and $52.7m of revenue in their latest fiscal years. Apyx Medical grew faster (9.9% against 8.2%). Iridex kept more of each dollar of sales as profit: a net margin of -8.4% against -21.2%.
| Latest fiscal year | Apyx MedicalAPYX, 2025 | IridexIRIX, 2025 |
|---|---|---|
| Revenue | $52.8m | $52.7m |
| Revenue growth | 9.9% | 8.2% |
| Net income | −$11.2m | −$4.4m |
| Operating margin | — | -4.9% |
| Net margin | -21.2% | -8.4% |
| Return on equity | -78.0% | -126.4% |
| Free cash flow | −$9.1m | −$2.3m |
| Cash | $31.7m | $6.0m |
| Total debt | $37.5m | $3.7m |
| Debt to equity | — | 75.9% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 205 | 93 |
| Market value | $110m | $12.6m |
| Price vs our value range | — | — |
| Moat score | 44 (Weak) | 34 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 83 buys, 0 sales |